AzTrials
AzTrials

Patellofemoral Pain SyndromePFPSNCT07698704

Popliteus Muscle Release Versus Patellofemoral Mobilization in Patellofemoral Pain Syndrome

A study testing Popliteus Muscle Release, Patellofemoral Mobilization and traditional therapy in people with Patellofemoral Pain Syndrome, run by Cairo University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study will be conducted to compare the effect of popliteus muscle release and patellofemoral mobilization on pain intensity, function, and quadriceps muscle strength in patients with patellofemoral pain syndrome? Read more about this study

Who is it for?
Ages 18 to 30 years
Conditions the study is for
Patellofemoral Pain Syndrome
What is being tested?
Popliteus Muscle Release, Patellofemoral Mobilization and traditional therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
48 participants
Where
No sites listed yet
Study dates
15 Jul 2026to 1 Nov 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Male and female participants aged 18-30 years.
  • minimum history of 3 months of unilateral PFP.
  • pain intensity score of ≥3 on a 10-cm Visual Analog Scale (VAS) for worst pain experienced during the previous week.
  • Pain reproduced during at least two of the following functional activities: stair ascent or descent, running, hopping, prolonged sitting, squatting, or kneeling.
  • Presence of pain on at least one of the following clinical tests: patellar compression test or palpation of the patellar facets.

Who cannot join

  • Clinical, x-ray, or MRI findings indicative of other specific pathology including osteoarthritis, meniscal, ligament or cartilage injury, apophysitis.
  • Recurrent patellar subluxation or dislocation.
  • Cortisone use over an extended period of time.
  • Previous surgery to the knee joint; trauma to the knee joint affecting the presenting clinical condition.
  • Lower limb deformities.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

About this study

This study will be conducted to compare the effect of popliteus muscle release and patellofemoral mobilization on pain intensity, function, and quadriceps muscle strength in patients with patellofemoral pain syndrome?

Read the detailed description

The gradual development of diffuse anterior knee pain is characteristic of patellofemoral pain (PFP), which is made worse by activities that put stress on the patellofemoral joint, such as running, stair climbing, and squatting. While 23% of the overall population has PFP, athletes can have a prevalence of 35%.Patellofemoral pain syndrome (PFPS) is a widespread disease with a significant impact on society, with a 22.7% prevalence in the general population.The patella is the largest sesamoid bone in the body and acts as a fulcrum to improve the mechanical advantage of the quadriceps. In full knee extension the patella does not articulate with the femoral condyles, and related to the lack of articular congruency, is able to glide more freely. The inferior patellar facet first contacts the femoral condyle around 20-30o of knee flexion.The popliteus tendon is a primary stabilizer of external knee rotation and has been described as the "fifth ligament of the knee." Injuries involving the posterolateral corner of the knee commonly involve the popliteus tendon; isolated injury to the popliteus tendon is relatively rare and usually involves a rotatory injury mechanism and symptoms of instability and pain.Myofascial release has been shown to improve pain, range of motion, and functional outcomes in individuals with knee disorders. By targeting fascial restrictions around the quadriceps, hamstrings, iliotibial band, and peri-patellar tissues, myofascial techniques help reduce tissue stiffness and abnormal tension that may contribute to altered patellar tracking and joint loading.Patellofemoral mobilization is considered an important intervention in the management of PFPS, particularly in patients presenting with pain, stiffness, or altered patellar tracking.Although both techniques are used to reduce anterior knee pain and improve function, current evidence is insufficient to determine which intervention is more effective. Therefore, further randomized controlled trials are needed to compare their effects on pain and functional outcomes in individuals with PFPS.

Being tested
Popliteus Muscle Release, Patellofemoral Mobilization, traditional therapy
Keywords
Popliteus Muscle Release, Patellofemoral Mobilization, Patellofemoral Pain Syndrome
Medical subject headings
Patellofemoral Pain Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Popliteus Muscle ReleaseOther

    the participant will lie supine and relaxed on a treatment bench. The therapist will begin the treatment by flexing the participant's knee to approximately 15-25 degrees. Then, the therapist will apply pressure to the popliteus muscle while simultaneously extending the knee to approximately 5 degrees of flexion. When the knee is extended, the pressure will be released. The therapist will repeat this procedure for up to 2 minutes plus tradional therapy

  • Patellofemoral MobilizationOther

    Following the clinical guidelines established by Brukner and Khan, the mobilization will be performed with the patient in a supine position to ensure complete relaxation of the quadriceps musculature, thereby minimizing joint compressive forces. The intervention will include multidirectional glides tailored to specific functional deficits:Superior glides,Inferior glides,Medial-lateral excursions and tilt mobilization.Each mobilization will be applied as a gentle sustained glide for duration of 30 to 60 seconds per repetition

  • traditional therapyOther

    patients will receive quadriceps muscle strength, hip extension strength, hamstring stretch.

Study groups in NCT07698704
Study groupRoleWhat they receive
Popliteus Muscle ReleaseExperimentalSixteen patients with patellofemoral pain syndrome will receive popliteus muscle release. plus traditional physical therapy three times a week for 4 weeks.
Receives: Other: Popliteus Muscle Release; Other: traditional therapy
Patellofemoral MobilizationExperimentalSixteen patients with patellofemoral pain syndrome will receive patellofemoral mobilization plus traditional physical therapy three times a week for 4 weeks.
Receives: Other: Patellofemoral Mobilization; Other: traditional therapy
traditional therapyActive comparatorSixteen patients with patellofemoral pain syndrome will receive traditional physical therapy three times a week for 4 weeks.
Receives: Other: traditional therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. pain intensity

    The scale used will be the visual analogue scale (VAS), which consists of a line, usually 10 cm long, the patient will be instructed to place a vertical mark on to indicate his/ her pain, ranging from no pain or discomfort (0), to the worst pain that could possibly feel

    Measured: up to four weeks

Secondary outcomes (2)
  1. knee disability

    The Kujala Arabic version will be used to assess knee disability. it is 13 items on the scale are used to assess subjective symptoms and functional restrictions. A score can have a minimum of 0 points or a maximum of 100 points.Lower scores reflect greater pain and disability

    Measured: up to four weeks

  2. quadriceps muscle strength

    A handheld dynamometer will be used to assess quadrecips muscle strength

    Measured: up to four weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jul 2026
  2. Study start15 Jul 2026 (estimated)
  3. Primary completion1 Nov 2026 (estimated)
  4. Study completion1 Nov 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Popliteus Muscle Release and Patellofemoral Mobilization
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
48 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07698704
Sponsor's protocol ID
P.T.REC/012/006557
Acronym
PFPS
Status last verified
Jul 2026
First submitted
7 Jul 2026
Last updated
13 Jul 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Popliteus Muscle Release, Patellofemoral Mobilization and traditional therapy in people with Patellofemoral Pain Syndrome, run by Cairo University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 13 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact mohamed Bahig, master (0 11 41644884, mohamed.bahig@the.suezuni.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

pain intensity (time frame: up to four weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in